Firefly Neuroscience to Showcase AI-Powered Brain Health Solutions at Florida Capital Event

Firefly Neuroscience Announces Participation in Florida Capital Event

Firefly Neuroscience, Inc. (NASDAQ: AIFF), an innovative Artificial Intelligence (AI) company focused on improving brain health outcomes, has announced its participation in the upcoming Capital Event Management Conference. The event is scheduled to take place from November 22-24, 2024, at the JW Marriott Miami in Aventura, Florida 1

1

2

Company Overview and AI-Powered Technology

Firefly Neuroscience specializes in developing cutting-edge solutions for patients with neurological and mental disorders. At the core of their offerings is the FDA-510(k) cleared Brain Network Analytics (BNA™) technology, which aims to revolutionize diagnostic and treatment monitoring methods for various conditions including depression, dementia, anxiety disorders, concussions, and ADHD 1

1

The company's BNA™ technology leverages artificial intelligence and machine learning, drawing insights from Firefly's extensive proprietary database. This database comprises standardized, high-definition longitudinal electroencephalograms (EEGs) from over 17,000 patients, representing twelve disorders as well as clinically normal individuals 2

2

Clinical Applications and Potential Impact

When used in conjunction with an FDA-cleared EEG system, BNA™ has the potential to provide clinicians with comprehensive insights into brain function. These insights could significantly enhance a clinician's ability to:

1. Accurately diagnose mental and cognitive disorders
2. Evaluate the most suitable therapy or drug to optimize patient outcomes 1

   1

   2

   2

Commercial Launch and Target Markets

Firefly Neuroscience is currently in the process of launching BNA™ commercially. The company is targeting two primary markets:

1. Pharmaceutical companies engaged in drug research and clinical trials
2. Medical practitioners for clinical use 1

   1

   2

   2

Investor Relations and Future Prospects

The company's participation in the Capital Event Management Conference presents an opportunity for potential investors to engage directly with Firefly's management. Interested parties can schedule one-on-one investor meetings through CEM representatives or by contacting KCSA Strategic Communications 1

1

2

Related Stories

Firefly Neuroscience to Showcase AI-Powered Brain Health Solutions at October Investor Conferences

Firefly Neuroscience Secures $12.4 Million Financing to Advance AI-Powered Brain Health Technology

Firefly Neuroscience's AI-Powered EEG Analytics Show Promise in Drug Development and Neuropsychiatric Care

Firefly Neuroscience Grants Inducement Shares to Executive Chairman, Highlighting AI-Driven Brain Health Solutions

About Capital Event Management (CEM)

CEM, the organizer of the Florida Capital Event, has been facilitating connections between issuers and investors since 2011. The company specializes in curating exclusive live events and virtual meetings, providing a forum for companies to raise capital, gain market support, and build relationships with leading North American small cap investors 1

1

2

Firefly's Market Position

As a NASDAQ-listed company (AIFF), Firefly Neuroscience represents an interesting intersection of artificial intelligence, neuroscience, and healthcare. With its FDA-cleared technology and a database built over 15 years, the company appears well-positioned to capitalize on the growing demand for innovative brain health solutions 1

1

2